SANTAX MEDICO A/S — Credit Rating and Financial Key Figures
CVR number: 66441318
Bredskifte Allé 11, Hasle 8210 Aarhus V
info@santax.com
tel: 70133022
Income statement (kDKK)
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 29 528.55 | 33 477.74 | 29 082.04 | 33 254.06 | 30 367.89 |
| Employee benefit expenses | -21 309.82 | -22 517.07 | -23 084.80 | -24 290.10 | -24 074.50 |
| Other operating expenses | - 202.48 | ||||
| Total depreciation | -1 721.96 | -1 703.79 | -1 656.67 | -1 410.60 | -1 528.82 |
| EBIT | 6 496.77 | 9 054.39 | 4 340.58 | 7 553.36 | 4 764.56 |
| Other financial income | 9.47 | 68.96 | 84.78 | 90.95 | 41.78 |
| Other financial expenses | - 130.24 | -62.58 | -49.15 | - 247.66 | - 144.48 |
| Pre-tax profit | 6 375.99 | 9 060.78 | 4 376.21 | 7 396.64 | 4 661.86 |
| Income taxes | -1 407.99 | -1 996.36 | - 874.49 | -1 611.83 | -1 035.73 |
| Net earnings | 4 968.01 | 7 064.42 | 3 501.72 | 5 784.81 | 3 626.13 |
Assets (kDKK)
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Buildings | 121.54 | ||||
| Machinery and equipment | 6 635.59 | 6 846.69 | 4 834.41 | 5 336.48 | 5 999.78 |
| Tangible assets total | 6 635.59 | 6 846.69 | 4 834.41 | 5 336.48 | 6 121.32 |
| Other receivables | 439.52 | 444.07 | 445.31 | 455.15 | 460.27 |
| Investments total | 439.52 | 444.07 | 445.31 | 455.15 | 460.27 |
| Non-current loans receivable | 125.84 | 194.80 | 279.51 | 363.59 | 366.62 |
| Long term receivables total | 125.84 | 194.80 | 279.51 | 363.59 | 366.62 |
| Finished products/goods | 9 934.38 | 11 907.29 | 8 800.77 | 9 499.82 | 9 994.62 |
| Advance payments | 845.15 | ||||
| Inventories total | 9 934.38 | 11 907.29 | 8 800.77 | 10 344.97 | 9 994.62 |
| Current trade debtors | 13 818.31 | 14 956.87 | 18 060.68 | 27 681.83 | 9 890.93 |
| Current amounts owed by group member comp. | 11 950.44 | 1 230.09 | 2 203.73 | 4 947.97 | 1 646.95 |
| Prepayments and accrued income | 302.72 | 554.20 | 414.41 | 499.69 | 534.53 |
| Current other receivables | 843.21 | 1 009.43 | 273.63 | 249.88 | 271.35 |
| Short term receivables total | 26 914.68 | 17 750.59 | 20 952.46 | 33 379.37 | 12 343.76 |
| Cash and bank deposits | 3 764.91 | 1 469.15 | 2 026.67 | 148.64 | 2 636.76 |
| Cash and cash equivalents | 3 764.91 | 1 469.15 | 2 026.67 | 148.64 | 2 636.76 |
| Balance sheet total (assets) | 47 814.91 | 38 612.60 | 37 339.12 | 50 028.20 | 31 923.35 |
Equity and liabilities (kDKK)
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 3 000.00 | 3 000.00 | 3 000.00 | 3 000.00 | 3 000.00 |
| Shares repurchased | 4 800.00 | 5 000.00 | 3 500.00 | 5 000.00 | 3 000.00 |
| Retained earnings | 2 637.78 | -3 994.21 | - 429.78 | -1 928.06 | 856.74 |
| Profit of the financial year | 4 968.01 | 7 064.42 | 3 501.72 | 5 784.81 | 3 626.13 |
| Shareholders equity total | 15 405.79 | 11 070.22 | 9 571.94 | 11 856.74 | 10 482.87 |
| Provisions | 4 653.14 | 4 198.99 | 3 352.79 | 3 580.81 | 3 005.91 |
| Non-current other liabilities | 2 125.04 | 2 194.08 | |||
| Non-current deferred tax liabilities | 2 270.87 | 2 341.26 | |||
| Non-current liabilities total | 2 125.04 | 2 194.08 | 2 270.87 | 2 341.26 | |
| Current loans from credit institutions | 3 748.00 | ||||
| Advances received | 8 072.46 | 4 962.75 | 7 197.85 | 6 140.53 | 6 975.09 |
| Current trade creditors | 10 832.02 | 7 784.46 | 7 803.30 | 10 443.29 | 3 577.58 |
| Short-term deferred tax liabilities | 1 032.99 | 2 226.36 | 880.49 | 1 714.83 | 1 033.32 |
| Other non-interest bearing current liabilities | 7 818.51 | 6 244.79 | 6 338.68 | 10 273.12 | 4 507.31 |
| Current liabilities total | 27 755.98 | 21 218.35 | 22 220.32 | 32 319.78 | 16 093.30 |
| Balance sheet total (liabilities) | 47 814.91 | 38 612.60 | 37 339.12 | 50 028.20 | 31 923.35 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.